GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Inventories, Finished Goods

Inventage Lab (XKRX:389470) Inventories, Finished Goods : ₩0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Inventories, Finished Goods?

Inventage Lab's quarterly finished goods declined from Sep. 2023 (₩287.7 Mil) to Dec. 2023 (₩0.0 Mil) but then stayed the same from Dec. 2023 (₩0.0 Mil) to Mar. 2024 (₩0.0 Mil).

Inventage Lab's annual finished goods increased from Dec. 2021 (₩47.8 Mil) to Dec. 2022 (₩295.6 Mil) but then declined from Dec. 2022 (₩295.6 Mil) to Dec. 2023 (₩0.0 Mil).


Inventage Lab Inventories, Finished Goods Historical Data

The historical data trend for Inventage Lab's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Inventories, Finished Goods Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
- - 47.76 295.63 -

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only 454.39 305.01 287.71 - -

Inventage Lab Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Inventage Lab (XKRX:389470) Business Description

Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines